COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,742 Articles (22,502 medRxiv, 8,240 bioRxiv)

Most recent first Previous |  Page 3053: Articles 30521-30530  | Next

Early Prediction of Disease Progression in 2019 Novel Coronavirus Pneumonia Patients Outside Wuhan with CT and Clinical Characteristics
Feng, Z., Yu, Q., Yao, S., Luo, L., Duan, J., Yan, Z., Yang, M., Tan, H., Ma, M., Li, T., Yi, D., Mi, Z., Zhao, H., Jiang, Y., He, Z., Li, H., Nie, W., Liu, Y., Zhao, J., Luo, M., Liu, X., Rong, P., Wang, W.
10.1101/2020.02.19.20025296 — Posted: 2020-02-23
Assessing the impact of a symptom-based mass screening and testing intervention during a novel infectious disease outbreak: The case of COVID-19
Ge, Y., McKay, B. K., Sun, S., Zhang, F., Handel, A.
10.1101/2020.02.20.20025973 — Posted: 2020-02-23
The efficacy of convalescent plasma for the treatment of severe influenza
Xu, Z., Zhou, J., Huang, Y., Liu, X., Xu, Y., Chen, S., Liu, D., Lin, Z., Liu, X., Li, Y.
10.1101/2020.02.20.20025593 — Posted: 2020-02-23
Clinical characteristics of 51 patients discharged from hospital with COVID-19 in Chongqing，China
lei, l., Jian-ya, G.
10.1101/2020.02.20.20025536 — Posted: 2020-02-23
Development and Evaluation of A CRISPR-based Diagnostic For 2019-novel Coronavirus
Hou, T., Zeng, W., Yang, M., Chen, W., Ren, L., Ai, J., Wu, J., Liao, Y., Gou, X., Li, Y., Wang, X., Su, H., Wang, J., Gu, B., Xu, T.
10.1101/2020.02.22.20025460 — Posted: 2020-02-23 Discussion: Offsite
Estimating the Asymptomatic Ratio of 2019 Novel Coronavirus onboard the Princess Cruises Ship, 2020
Mizumoto, K., Kagaya, K., Zarebski, A., Chowell, G.
10.1101/2020.02.20.20025866 — Posted: 2020-02-23
Estimating the risk of 2019 Novel Coronavirus death during the course of the outbreak in China, 2020
Mizumoto, K., Chowell, G.
10.1101/2020.02.19.20025163 — Posted: 2020-02-23 Discussion: Onsite
ACP risk grade: a simple mortality index for patients with confirmed or suspected severe acute respiratory syndrome coronavirus 2 disease (COVID-19) during the early stage of outbreak in Wuhan, China
Lu, J., Hu, S., Fan, R., Liu, Z., Yin, X., Wang, Q., Lv, Q., Cai, Z., Li, H., Hu, Y., Han, Y., Hu, H., Gao, W., Feng, S., Liu, Q., Li, H., Sun, J., Peng, J., Yi, X., Zhou, Z., Guo, Y., Hou, J.
10.1101/2020.02.20.20025510 — Posted: 2020-02-23
Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan, China
Yuan, M., Yin, W., Tao, Z., Tan, W., Hu, Y.
10.1101/2020.02.22.20024927 — Posted: 2020-02-23
Effectiveness of intervention strategies for Coronavirus Disease 2019 and an estimation of its peak time
pan, j., yao, y., liu, z., li, m., wang, y., dong, w., kan, h., wang, w.
10.1101/2020.02.19.20025387 — Posted: 2020-02-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).